Overall rank by patents
#48,478
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Loci Orthopaedics Limited
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
5
Total patents granted
2
CPC technology areas
21.4
Avg claims per patent
-
5-year filing velocity
The verdict
Loci holds 5 US patents across 2 technology areas, rank #48,478 of 50,000 tracked assignees.
- #48,478
- of 50,000 US assignees by volume
- Top 27%
- by Innovation Score (44.0/100)
- 21.4
- avg claims per patent
Portfolio overview
Loci Orthopaedics Limited has been granted 5 US utility patents between 2020 and 2024, placing Loci Orthopaedics Limited at rank #48,478 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.4 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a Foreign Corporation, Loci Orthopaedics Limited is one of the more focused assignees in the PatentsView dataset. By volume, Loci sits between Liverpool School Of Tropical Medicine (5 patents, rank #48,474) and Los Angeles Biomedical Research Institute (5 patents, rank #48,482) - the closest US assignees by grant volume. The composite Innovation Score of 44.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Loci Orthopaedics Limited's 21.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Loci Orthopaedics Limited against peers pursuing similar technology classes.
Who files at Loci's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Liverpool School…
Liverpool School of Tropical Medicine
5 patents
- Livescribe
Livescribe Inc.
5 patents
- Living technology…
Living technology (shenzhen) CO., LTD.
5 patents
- Local Bounti Oper…
Local Bounti Operating Company LLC
5 patents
- Loftie
Loftie Inc.
5 patents
- Logicblox
LogicBlox, Inc.
5 patents
- Lombardini S r L
Lombardini S.r.L
5 patents
- Los Angeles Biome…
Los Angeles Biomedical Research Institute
5 patents
- Loci Orthopaedics ◀
Loci Orthopaedics Limited
5 patents
What this shows Loci holds 5 patents at rank #48,478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Loci
By rank, the assignees closest to #48,478 in granted patent volume.
- Liverpool School Of Tropical Medicine #48,474 · 5 patents
- Livescribe Inc. #48,475 · 5 patents
- Living Technology (shenzhen) Co., Ltd. #48,476 · 5 patents
- Local Bounti Operating Company Llc #48,477 · 5 patents
- Loftie Inc. #48,479 · 5 patents
- Logicblox, Inc. #48,480 · 5 patents
- Lombardini S.r.l #48,481 · 5 patents
- Los Angeles Biomedical Research Institute #48,482 · 5 patents
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in Loci's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
Loci's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 20.0% |
| 2023 | 2 | 40.0% |
| 2024 | 2 | 40.0% |
Which technologies does Loci Orthopaedics Limited patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Frequently Asked Questions
How many patents does Loci Orthopaedics Limited hold?
Loci Orthopaedics Limited holds 5 US granted patents filed between 2020 and 2024, spanning 2 technology areas.
What is Loci Orthopaedics Limited's Innovation Score?
Loci Orthopaedics Limited has an Innovation Score of 44.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Loci Orthopaedics Limited focus on?
Loci Orthopaedics Limited's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 5 patents. The company has filed patents in 2 CPC subclasses total.
Is Loci Orthopaedics Limited's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Loci Orthopaedics Limited.
What does claim depth mean for Loci Orthopaedics Limited's patents?
Loci Orthopaedics Limited's patents average 21.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Loci Orthopaedics Limited patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Loci's 5 grants land it in the top 27% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Loci ranks #48,478 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.